We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Boswellia wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
7 of 7 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
11 of 13 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Boswellia and Soy Isoflavones have evidence — compare verdict strength side-by-side.
300-500mg standardized extract (30-40% AKBA), 2-3x daily
With meals containing fat
Standardized extract (30-40% AKBA or 65% boswellic acids)
40-80mg isoflavones daily
Divided doses with meals, Consistent daily timing
Standardized soy isoflavone extract
4-8 weeks
4-8 weeks
2-4 weeks
4-12 weeks
6-12 months
8-12 weeks
Initial use
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Nutrients (2025) · Meta analysis · n=4599
Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Phytotherapy research : PTR (2017) · Meta analysis · n=1741
Z. officinale showed improvement of pain over placebo.
Oral herbal therapies for treating osteoarthritis
The Cochrane database of systematic reviews (2014) · Meta analysis · n=5980
Seventeen studies of confirmatory design (sample and effect sizes pre-specified) were mostly at moderate risk of bias.
Soy isoflavones prevent bone resorption and loss, a systematic review and meta-analysis of randomized controlled trials
Critical reviews in food science and nutrition (2020) · Meta analysis · n=5313
Soy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.
Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Advances in nutrition (Bethesda, Md.) (2025) · Meta analysis · n=3285
Addressing public health concerns may promote soy foods as high-quality plant protein sources with low environmental impact and cost, particularly benefiting postmenopausal women and aligning with sustainable dietary patterns and guidelines.
Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis
PeerJ (2025) · Meta analysis · n=533
In October 2024, we screened 2,099 articles, of which 12 were eligible for meta-analysis, and found that soy isoflavones were effective for treating menopausal symptoms (seven studies, 533 participants, Hedges' g = -0.25, 95% CI [-0.42 to -0.08], p = 0.00).
Based on multiple meta-analyses showing pain reduction in osteoarthritis. Effects may vary significantly by extract standardization (AKBA content) and bioavailability enhancement. Studies primarily used 30-40% AKBA extracts.
Meta-analysis of 533 participants showed effectiveness for menopausal symptoms. Effect size appears modest and heterogeneity was noted across studies. Individual response varies significantly.
AI-estimated from published studies. Interpret as directional guidance.
Boswellia has a higher evidence score (7.5/10 vs 6/10) and wins in 2 of 3 categories.
For reduce inflammation, Boswellia has a higher relevance score (95 vs 60).
No known interactions between Boswellia and Soy Isoflavones have been documented in our database. However, always consult a healthcare provider before combining supplements.